课题基金 / 基金详情

COST-EFFECTIVENESS OF THIRD GENERATION CEPHALOSPORIN FOR TREATMENT OF UTI

COST-EFFECTIVENESS OF THIRD GENERATION CEPHALOSPORIN FOR TREATMENT OF UTI
第三代头孢菌素治疗尿路感染的成本效益
批准号：
3763531
负责人：
ALEJANDRO HOBERMAN
金额：
$0.0万
依托单位：
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3763531
关键词：
beta lactam antibiotic cephalosporins clinical trials drug screening /evaluation health care cost /financing human subject human therapy evaluation infant human (0-1 year) intravenous administration oral administration pediatric pharmacology preschool child (1-5) urinary tract disorder chemotherapy urinary tract disorder diagnosis urinary tract imaging /visualization urinary tract infection

项目摘要

项目成果

ALEJANDRO HOBERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
口服抗菌药物与静脉抗菌药物的随机临床试验 1~24岁发热儿童尿路感染的治疗 月份。预后的主要衡量标准是肾脏疤痕形成。 通过6个月的DMSA肾脏扫描确定的UTI指数 在学习进入之后。
英文摘要
A randomized clinical trial of oral vs. intravenous antimicrobial treatment for urinary tract infection in febrile children aged 1-24 months. The primary measure of outcome is renal scarring attributable to the index UTI, as determined by DMSA renal scans obtained six months after study entry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media
Efficacy of Antimicrobials in Young Children with AOM
Efficacy of Antimicrobials in Young Children with AOM
海外基金